Register entry

Noramco, LLC

Registered sites
1
Drug products
15
Live patents
0
Countries
1
Base
United States
Authorisation

Registered operations

What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.

Active ingredient (API) manufactureparticle size reductionRepackaging
Sites

Facilities

1
SiteLocationOperationsFEI
Noramco, LLCWilmington, DEUnited StatesActive ingredient (API) manufacture, particle size reduction, Repackaging2522445
Catalogue

Marketed products

15

Showing 15 of 15.

BrandGeneric nameFormCategory
-BuprenorphinePOWDERBULK INGREDIENT
-Buprenorphine HydrochloridePOWDERBULK INGREDIENT
-Codeine PhosphatePOWDERBULK INGREDIENT
-Hydrocodone BitartratePOWDERBULK INGREDIENT
-Hydromorphone HydrochloridePOWDERBULK INGREDIENT
-Lisdexamfetamine DimesylatePOWDERBULK INGREDIENT
-Methylnaltrexone BromidePOWDERBULK INGREDIENT
-Methylphenidate HydrochloridePOWDERBULK INGREDIENT
-Morphine SulfatePOWDERBULK INGREDIENT
-Naloxone Hydrochloride DihydratePOWDERBULK INGREDIENT
-Naltrexone BasePOWDERBULK INGREDIENT
-Naltrexone HydrochloridePOWDERBULK INGREDIENT
-Oxycodone HydrochloridePOWDERBULK INGREDIENT
-Oxymorphone HydrochloridePOWDERBULK INGREDIENT
-Purified Oxycodone BasePOWDERBULK INGREDIENT
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.